NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-298 Cr | ₹-150 Cr | ₹-61 Cr | ₹-96 Cr | ₹-84 Cr |
What is the latest Cash Flow from Investing Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-298 Cr |
| Mar2024 | ₹-150 Cr |
| Mar2023 | ₹-61 Cr |
| Mar2022 | ₹-96 Cr |
| Mar2021 | ₹-84 Cr |
How is Cash Flow from Investing Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-298 Cr | Negative | |
| Mar2024 | ₹-150 Cr | Negative | |
| Mar2023 | ₹-61 Cr | Negative | |
| Mar2022 | ₹-96 Cr | Negative | |
| Mar2021 | ₹-84 Cr | - | |
Compare Cash Flow from Investing Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹16,197.2 Cr | -4.4% | -7% | 10.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -4.4% |
-7% |
10.7% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses